Position in LQDA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$2,628,213
-$325,716 QoQ
Shares Held
69,640
-18.7% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $884,912,076 across 47 Drug Manufacturers - Specialty & Generic names. LQDA ranks #18 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,650,753 | $431,555,511 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,872,811 | $116,649,065 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
186,794 | $110,765,104 | |
| 4 | VTRS |
Viatris Inc
|
3,838,534 | $51,858,592 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
380,589 | $50,138,793 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
709,808 | $16,985,705 | |
| 7 | ALKS |
Alkermes plc.
|
380,722 | $13,462,329 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,411,199 | $13,434,613 |
All Filings in LQDA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,628,213 | 69,640 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $2,953,929 | 85,646 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $2,139,946 | 94,105 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,173,133 | 94,152 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,224,854 | 83,041 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $979,442 | 83,286 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $730,630 | 73,063 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $874,332 | 72,861 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $1,011,171 | 68,554 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $59,608 | 4,955 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $31,414 | 4,955 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $43,755 | 5,574 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $37,417 | 5,415 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $34,493 | 5,415 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $29,457 | 5,415 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $38,237 | 8,770 | Shares | Defined | 2022-08-22 | |
| 2021-03-31 | $7,970 | 2,963 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $9,560 | 3,241 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $15,945 | 3,241 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $28,215 | 3,351 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $8,802 | 1,869 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||